Stay updated on Neratinib with Trastuzumab in ER+ HER2+ Breast Cancers Clinical Trial

Sign up to get notified when there's something new on the Neratinib with Trastuzumab in ER+ HER2+ Breast Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Neratinib with Trastuzumab in ER+ HER2+ Breast Cancers Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision updated to v3.5.4, indicating a new version of the study record history. This update does not change the underlying study data or trial details.
    Difference
    0.1%
    Check dated 2026-05-15T23:59:24.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The page’s displayed revision/version number updates from **v3.5.2** to **v3.5.3**, indicating a site release without changing the trial record text.
    Difference
    0.1%
    Check dated 2026-04-24T17:10:02.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2. Removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T13:59:34.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    Added a new Study Status section to the version history to reflect the trial's current status across revisions. An entry from 2026-03-12 was removed.
    Difference
    0.3%
    Check dated 2026-04-10T08:58:58.000Z thumbnail image
  8. Check
    71 days ago
    Change Detected
    Summary
    Added revision v3.5.0 and removed revision v3.4.3 from the history.
    Difference
    0.1%
    Check dated 2026-03-19T22:24:31.000Z thumbnail image
  9. Check
    78 days ago
    Change Detected
    Summary
    A new site revision 3.4.3 adds Oversight and Study Status entries, replacing the previous revision 3.4.2.
    Difference
    0.5%
    Check dated 2026-03-12T19:45:21.000Z thumbnail image

Stay in the know with updates to Neratinib with Trastuzumab in ER+ HER2+ Breast Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Neratinib with Trastuzumab in ER+ HER2+ Breast Cancers Clinical Trial page.